Progression of coronary artery calcification in type 1 diabetes - The importance of glycemic control

被引:111
作者
Snell-Bergeon, JK
Hokanson, JK
Jensen, L
MacKenzie, T
Kinney, G
Dabelea, D
Eckel, RH
Ehrlich, J
Garg, S
Rewers, M
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Prevent Med & Biometr, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA
[3] Dartmouth Coll, Hanover, NH USA
[4] Colorado Heart Imaging Ctr, Denver, CO USA
[5] Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA
关键词
D O I
10.2337/diacare.26.10.2923
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE-Coronary artery disease (CAD) occurs earlier in life and is more often fatal in people with type I diabetes. This excess risk seems to be higher than in those with type 2 diabetes and is poorly explained by conventional risk factors. The role of glycemic control is controversial and has not been previously addressed in a prospective manner using a reliable marker for subclinical CAD, such as coronary artery calcification (CAC), measured by electron beam computed tomography (EBCT). RESEARCH DESIGN AND METHODS-We measured CAC twice during an interval of 2.7 years in 109 men and women with type 1 diabetes (aged 22-50 years). Progression of CAC was found in 21 patients, based on change in the square root-transformed volume score. RESULTS-In multiple logistic regression, CAC progression was associated with baseline hyperglycemia (odds ratio [OR] 7.11, 95% CI 1.38-36.6, P = 0.02), adjusted for the presence of CAC at baseline (P = 0.01), duration of diabetes (P = 0.02), sex (P = 0.09), and age (P = 0.27). There was also a significant interactive effect of higher insulin dose and higher BMI (P = 0.03). CONCLUSIONS-In conclusion, in this young cohort with type I diabetes, suboptimal glycemic control (HbA(1c) >7.5%) was a strong risk factor for progression of CAC. Insulin resistance may also play a role.
引用
收藏
页码:2923 / 2928
页数:6
相关论文
共 32 条
[1]   Influence of lipid-lowering therapy on the progression of coronary artery calcification - A prospective evaluation [J].
Achenbach, S ;
Ropers, D ;
Pohle, K ;
Leber, A ;
Thilo, C ;
Knez, A ;
Menendez, T ;
Maeffert, R ;
Kusus, M ;
Regenfus, M ;
Bickel, A ;
Haberl, R ;
Steinbeck, G ;
Moshage, W ;
Daniel, WG .
CIRCULATION, 2002, 106 (09) :1077-1082
[2]   QUANTIFICATION OF CORONARY-ARTERY CALCIUM USING ULTRAFAST COMPUTED-TOMOGRAPHY [J].
AGATSTON, AS ;
JANOWITZ, WR ;
HILDNER, FJ ;
ZUSMER, NR ;
VIAMONTE, M ;
DETRANO, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 15 (04) :827-832
[3]  
*AM DIAB ASS, 1998, DIABETES CARE, V21, P1551
[4]  
Amer Diabet Assoc, 2002, DIABETES CARE, V25, P213
[5]  
[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005
[6]   Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease by an electron-beam computed tomographic study [J].
Arad, Y ;
Newstein, D ;
Cadet, F ;
Roth, M ;
Guerci, AD .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (12) :2051-2058
[7]   Predictive value of electron beam computed tomography of the coronary arteries - 19-month follow-up of 1173 asymptomatic subjects [J].
Arad, Y ;
Spadaro, LA ;
Goodman, K ;
LledoPerez, A ;
Sherman, S ;
Lerner, C ;
Guerci, AD .
CIRCULATION, 1996, 93 (11) :1951-1953
[8]   Rates of progression of coronary calcium by electron beam tomography [J].
Budoff, MJ ;
Lane, KL ;
Bakhsheshi, H ;
Mao, S ;
Grassmann, BO ;
Friedman, BC ;
Brundage, BH .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (01) :8-11
[9]   Effect of HMG-Coa reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography [J].
Callister, TQ ;
Raggi, P ;
Cooil, B ;
Lippolis, NJ ;
Russo, DJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (27) :1972-1978
[10]   Coronary artery disease: Improved reproducibility of calcium scoring with an electron-beam CT volumetric method [J].
Callister, TQ ;
Cooil, B ;
Raya, SP ;
Lippolis, NJ ;
Russo, DJ ;
Raggi, P .
RADIOLOGY, 1998, 208 (03) :807-814